Serrated lesions of the colorectum are the precursors of perhaps one-third of colorectal cancers (CRCs). Cancers arising in serrated lesions are usually in the proximal colon, and account for a disproportionate fraction of cancer identifi ed after colonoscopy. We sought to provide guidance for the clinical management of serrated colorectal lesions based on current evidence and expert opinion regarding defi nitions, classifi cation, and signifi cance of serrated lesions. A consensus conference was held over 2 days reviewing the topic of serrated lesions from the perspectives of histology, molecular biology, epidemiology, clinical aspects, and serrated polyposis. Serrated lesions should be classifi ed pathologically according to the World Health Organization criteria as hyperplastic polyp, sessile serrated adenoma / polyp (SSA / P) with or without cytological dysplasia, or traditional serrated adenoma (TSA). SSA / P and TSA are premalignant lesions, but SSA / P is the principal serrated precursor of CRCs. Serrated lesions have a distinct endoscopic appearance, and several lines of evidence suggest that on average they are more diffi cult to detect than conventional adenomatous polyps. Effective colonoscopy requires an endoscopist trained in the endoscopic appearance of serrated lesions. We recommend that all serrated lesions proximal to the sigmoid colon and all serrated lesions in the rectosigmoid > 5 mm in size, be completely removed. Recommendations are made for post-polypectomy surveillance of serrated lesions and for surveillance of serrated polyposis patients and their relatives.
INTRODUCTION
Serrated lesions of the colorectum are characterized histologically by a serrated (or saw-toothed) appearance of the crypt epithelium ( Figure 1a-c ) . Th irty years ago, serrated lesions were called " hyperplastic " polyps (HPs) and were thought to have no malignant potential ( 1 ) . Since then, a subset of serrated lesions has been established as the precursor of a group of colorectal cancers (CRCs) that exhibit hypermethylation and arise primarily in the proximal colon, and which may account for one-third of all CRCs ( 2 -11 ) . Subtypes of serrated lesions ( Table 1 ) have diff erent molecular profi les and variable potential to develop into CRC ( 12 -19 ) .
Th e purposes of this consensus report are to summarize the pathological, molecular, and endoscopic features of serrated lesions, to increase awareness of the threat posed by these lesions, to describe the endoscopic appearance of these lesions, to stress the importance of accurate detection and complete excision, and to provide recommendations regarding post-resection management. Table 2 summarizes the key concepts and recommendations in this article.
METHODS
Th is statement is the result of a two-day consensus meeting held in Cleveland in 2010 and sponsored by the National Institutes of Health. Th e panel members were chosen for their expertise in endoscopy, surgery, pathology, epidemiology, and / or molecular aspects of serrated lesions and / or serrated polyposis. In preparation of this report, a literature review was conducted in MEDLINE, from January 1996 to October, 2011, using the terms
PATHOLOGY OF SERRATED LESIONS

Overview
Serrated lesions of the colorectum are currently classifi ed by the WHO into three general categories ( 19 ) ( Table 1 ) . Th e rationale for the terminology in Table 1 has been described previously ( 11, 21 ) . Th e terms " sessile serrated adenoma " and " sessile serrated polyp " are considered synonyms, and both are acceptable.
In general, the subtypes of serrated lesions are identifi ed by cytological and architectural features and by the location and extent of the proliferative zone ( 14, 21 ) as described below. Th e specifi c causes of the cytological, architectural, and proliferative alterations are not known, but they are presumed to result from epigenetic alterations in genes responsible for cell proliferation and diff erentiation (caused by hypermethylation of promoter DNA), as well as genetic changes such as mutations in BRAF .
Hyperplastic polyps (HP)
HPs are characterized by the presence of straight crypts, which extend symmetrically from the surface of the polyp to the muscularis mucosa without signifi cant distortion ( Figure 1a -c ) . Th e crypts are typically wider at the polyp surface compared with the base, and do not show horizontal or irregular branching ( Figure 1a -c ) . Similarly, the degree of " serration " is more pronounced in the upper half and surface of the polyps than at the base. Depending on the subtype (see below), the epithelium may be lined with a variety of cell types, including microvesicular mucinous cells, goblet cells, and undiff erentiated cells. Neuroendocrine cells are oft en prominent at the base of the polyp. In general, mitoses are confi ned to the basal half of the polyp. In many cases, the basement membrane underneath the surface epithelium is thickened as well. Only minimal cytological atypia is present in HPs. Th e cells show small oval or slightly elongated nuclei, without stratifi cation or hyperchromaticity. It is important to consider overall architecture, as cytological atypia without signifi cant architectural changes may be due to regenerative changes in an infl amed HP.
HPs can be subdivided histologically into microvesicular (MVHP), goblet cell (GCHP), and mucin-poor HP types based on the characteristics of lining epithelium. Mucin-poor HPs are rare, and little is known about their molecular features or natural history. MVHPs and GCHPs are well characterized and display considerable diff erences in molecular and histological features as well as anatomic distribution within the colon. Although we describe the pathological features of these HP subtypes, any clinical importance of the distinctions is currently uncertain.
MVHPs are characterized by the presence of small droplet ( " microvesicular " ) mucin within the cytoplasm of most cells. Scattered goblet cells are common as well ( Figure 1a ). MVHPs are located predominantly in the left colon, although 10 -15 % occur in the transverse and right colon. Multiple MVHPs are common, particularly in the rectum.
In contrast to MVHPs, GCHPs are characterized by the nearly exclusive presence of goblet cells ( Figure 1b ). Cells with microvesicular mucin are not present. Compared with MVHPs, GCHPs show few or no luminal serrations. Although the proliferative zone remains located in the basal portion of the crypts, it is oft en limited to only a few cells. GCHPs are also more common in the left colon ( ≈ 90 % ), and are typically very small ( < 0.5 cm).
Mucin-poor HPs show little or no cytoplasmic mucin. Th ey have a luminal serration pattern similar to MVHPs, but also reveal increased nuclear atypia in the form of large, round, hyperchromatic nuclei, but without pseudostratifi cation ( Figure 1c ). One theory is that mucin-poor HPs represent injured MVHPs, with infl ammation and reactive epithelial changes.
Sessile serrated adenoma / polyp (SSA / P)
SSA / Ps are characterized by the presence of a disorganized and distorted crypt growth pattern that is usually easily identifi able upon low-power microscopic examination ( 14, 21 ) . ( Figure 2a ). Crypts, particularly at the basal portion of the polyp, may appear dilated and / or branched, particularly in the horizontal plane, which leads to the formation of " boot, " " L, " or " anchor " -shaped crypts ( Figure 2a ) . Th e basal half of the crypts oft en contain excessive ( " hyper " ) serration and mature goblet cells and mucinous cells. Upon Ki67 staining (a stain for proliferating cells), positive cells may be located anywhere in the crypt from the base to the surface, and oft en in an irregular and asymmetric pattern ( 21 ) . Other common cytological features include various degrees of nuclear atypia (e.g., cells with open nuclei and prominent small nucleoli), dystrophic goblet cells, and an absence of neuroendocrine cells. Foci of cells with elongated penicillate nuclei and eosinophilic cytoplasm that are reminiscent of cells seen in TSAs (see below) may be present. SSA / Ps oft en produce excessive extracellular mucin, and it is not unusual to see mucin fi ll the lumen of dilated crypts and coat the surface of the polyp. Some SSA / Ps show prominent lipoma-like adipose tissue in the submucosa, but it is unclear if this phenomenon represents a chance association of SSA / P with a submucosal lipoma or some Serrated lesions of the colorectum should be classifi ed histologically as hyperplastic polyp (HP), sessile serrated adenoma / polyp (SSA / P) with or without cytologic dysplasia, or traditional serrated adenoma (TSA). Exceptions and subcategories are discussed in the text. Clinicians and pathologists within institutions should work collaboratively to achieve a common usage and understanding of terminology of serrated lesions.
2 SSA / P and TSA are pre-cancerous lesions. SSA / P is the principal precursor of hypermethylated colorectal cancers (cancers with the CpG island methylator phenotype). This pathway occurs primarily in the proximal colon.
3 SSA / P is distinguished from HP pathologically by fi ndings of crypt distortion, particularly in the crypt base, in SSA / P. We recommend that a single unequivocal architecturally distorted, dilated, and / or horizontally branched crypt, particularly if it is associated with inverted maturation, is suffi cient for a diagnosis of SSA / P. Most large serrated lesions in the proximal colon are SSA / Ps.
4
SSA / P with cytological dysplasia is a more advanced lesion in the progression to cancer compared with SSA / P without cytological dysplasia.
Endoscopy
5
SSA / P and hyperplastic polyps in the proximal colon have a distinct endoscopic appearance, which includes a " mucus cap " , color usually similar to normal mucosa, and indistinct edges. All colonoscopists should be able to recognize serrated lesions. form of epithelial -mesenchymal interaction. Herniation of crypts through the muscularis mucosa, giving rise to a " pseudoinvasive " or " inverted " growth pattern, is not unusual, but the pathogenesis of this fi nding is unknown. Pseudoinvasion can also be seen in HPs and therefore, although more common in SSA / Ps, is not pathognomonic of SSA / P.
Differential diagnosis: MVHP vs. SSA / P
Serrated lesions may show MVHP pathology in one area and SSA / P morphology, such as dilated and irregular crypts, in another. Th ese lesions have been sometimes interpreted as evidence of progression of MVHP to SSA / P, but MVHP-like features could simply be part of the histological spectrum of SSA / P. A diffi cult and unresolved diagnostic problem relates to polyps that show nearly exclusive MVHP morphology, but in addition show only a few (or even just one), irregular, hyperdilated, and distorted crypts of the type seen in SSA / P. Unfortunately, the minimum criteria necessary to establish a diagnosis of an SSA / P have not been set. We recommend that the presence of at least one unequivocal architecturally distorted, dilated, and / or horizontally branched crypt, particularly if it is associated with inverted maturation, is suffi cient for a diagnosis of SSA / P. In clinical practice, there is substantial interobserver variation among pathologists in the diff erentiation of SSA / P from HP, and agreement between pathologists is moderate at best, including between expert pathologists ( 22 -24 ) .
SSA / P with cytological dysplasia
Recent data suggest that SSA / P with foci of conventional (tubular or tubulovillous) adenoma-like dysplasia represent progression towards carcinoma. Preliminary evidence indicates that a substantial portion of these lesions demonstrate inactivation of the mismatch repair gene MLH1 , and the dysplastic areas oft en demonstrate microsatellite instability ( 25 ) . Such lesions were previously reported in the literature as " mixed hyperplastic / adenomatous polyps " . Th e term " mixed polyp " is discouraged because it does not convey the concept that combined features represent progression of an SSA / P towards carcinoma, and that the cytologically dysplastic portion has molecular characteristics diff erent from conventional adenomas. Histologically, SSA / Ps with conventional adenoma-like dysplasia usually show a portion of the polyp with typical SSA / P morphology and another with an abrupt transition to cytologically dysplastic areas ( Figure 2b ). Conventional adenoma-like dysplastic areas are characterized by the presence of elongated cells with penicillate and hyperchromatic pseudostratifi ed nuclei, amphophilic cytoplasm, and increased mitoses. Th e dysplastic areas look similar to a conventional tubular or tubulovillous adenoma cytologically. Although areas of conventional adenomatous dysplasia may show a range of cytological atypia with features similar to " low-grade " or " high-grade " dysplasia in a conventional adenoma, the significance of the grade of dysplasia in SSA / P has not been evaluated. We recommend that SSA / P with any conventional cytological dysplasia be considered an " advanced " polyp with clinical signifi cance similar to high-grade dysplasia in conventional adenomas.
Although poorly studied, another form of " dysplasia " may rarely be seen in SSA / P, which is referred to here as " serrated dysplasia " ( 19 ) . Some cases may show a proliferation of atypical cells that are more cuboidal in shape, have eosinophilic cytoplasm, enlarged round nuclei with open vesicular prominent chromatin, and prominent nucleoli in addition to increased mitoses. Although not particularly serrated in its architectural growth pattern owing to the presence of prominent eosinophilic cytoplasm, some experts believe that serrated dysplasia is also a histological biomarker of neoplasia progression ( 19 ) .
Traditional serrated adenoma (TSA)
Histologically, TSAs oft en show a complex and distorted tubulovillous or villous ( " fi liform " ) confi guration ( Figure 3 ). In many cases, the villi are elongated with bulbous tips, and have been termed fi liform TSAs ( 26 ) . A recent study described a characteristic pattern of budding of proliferative crypts situated perpendicular to the long axis of fi liform or villous structures of TSAs (ectopic crypt formation) ( 21 ) . Th e authors suggested that this 
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TSAs, these eosinophilic cells show increased size of the nuclei, hyperchromaticity, stratifi cation, and increased mitotic activity. Th e luminal serrated growth pattern is oft en more exaggerated, complex, and distorted than typical TSAs. Some cases may show a mixture of both types of dysplasia (both serrated and conventional adenoma-like) within the same polyp or even within the same crypt / villous unit. Th e risk of malignancy in TSA, and the rapidity of progression to carcinoma, is unknown.
As discussed in the molecular section of this article, there is a greater heterogeneity in the molecular profi le of TSA compared with SSA / P. Th is may be partly due to inconsistency in the diagnostic criteria used for this lesion.
Unclassifi able serrated polyps
Some " serrated " lesions may be diffi cult to classify into one of the above discrete categories. Aside from histological diffi culties owing to overlapping features, logistical factors such as poor orientation of specimens, poor staining, severe cautery artifact, or insuffi cient tissue may impede the ability to establish a precise diagnosis. In such cases, the term " serrated polyp unclassifi ed " is acceptable. However, pathologists should make their best attempt to determine whether dysplasia is present, even when the diagnosis is diffi cult.
Conventional tubular, tubulovillous, or villous adenomas may occasionally show areas with a serrated growth pattern. Unfortunately, the biological signifi cance of these polyps has not been studied. Th ey are generally distinguished from other types of serrated polyps by the absence of areas of SSA / P or TSA morphology. Th e term " conventional adenoma (tubular, tubulovillous, and villous) with a serrated growth pattern " is an acceptable term for these lesions. A recent study identifi ed a distinctive group of conventional adenomas that met the above criteria and additionally exhibited cystic glands and bright cytoplasmic eosinophilia ( 28 ) . Th e authors reported these lesions to be KRAS and BRAF wild type and CpG island methylator phenotype (CIMP)-low. In that study, polyps were found in patients with at least one synchronous SSA / P.
MOLECULAR FEATURES OF THE SERRATED PATHWAY OF CARCINOGENESIS
Every CRC has a unique molecular profi le ( 29 ) . However, there are at least three general molecular mechanisms by which genetic and epigenetic events can lead to CRC: chromosomal instability, defective DNA mismatch repair leading to microsatellite instability (MSI), and epigenetic DNA promoter hypermethylation leading to CIMP. Although there can be overlap of these mechanisms within any single cancer, the dominant mechanism has distinct clinical associations, including the type of benign precursor lesion. Th e epigenetic CIMP pathway is considered to be the major mechanism driving the serrated pathway to CRC.
Serrated polyp -carcinoma sequence: the epigenetic (hypermethylator) mechanism
Th is mechanism of colorectal carcinogenesis is based on abnormal promoter CpG island hypermethylation ( 29 -36 ) . Methylation phenomenon is related to loss of (normal) anchorage of crypts to the underlying muscularis mucosa. It is the most characteristic histological feature of this type of polyp. Th e predominant cell in TSA has abundant eosinophilic cytoplasm and a basal or centrally placed slightly elongated nucleus with an open / even chromatin pattern. Th e epithelium is usually pseudostratifi ed but shows little if any proliferative activity and is oft en interpreted as a form of dysplasia. Th ere is some controversy as to whether this epithelium represents a type of " metaplasia " or " senescence " rather than true dysplasia as it diff ers from the more cytologically atypical and proliferative appearance of dysplastic epithelium in conventional adenomas. Although a prominent and characteristic feature of TSAs, this type of eosinophilic epithelium may also be present in SSA / P with or without conventional adenoma-like cytological dysplasia. Goblet cells may also be a component of serrated crypts in TSA, and in some cases are prominent.
Both conventional adenoma-like dysplasia and serrated dysplasia can be observed in TSA. With neoplastic progression, it is believed that TSAs acquire increasing degrees of cytological atypia before the development of carcinoma. However, there is no consensus on identifi cation and grading of dysplasia in TSA. Until agreement is reached, conventional adenoma-like dysplasia should be graded similar to the way it is graded in conventional adenomas (highgrade vs. low-grade). A recent study showed that 25 % of TSAs from Korea had changes described as high-grade dysplasia and 8 % showed intramucosal adenocarcinoma ( 27 ) . High-grade serrated dysplasia shows cells with strongly eosinophilic cytoplasm, but in contrast to the eosinophilic epithelium characteristic of many of CpG islands within promoter regions of genes is a normal way of reducing gene expression. More methylation means less expression, and if the gene being silenced is a tumor-suppressor gene, then loss of function may facilitate carcinogenesis. Th e extent of promoter CpG island hypermethylation in neoplasms varies considerably. Hypermethylation of some genes occurs in most CRCs, but it is the global nature of the methylation that distinguishes the subset of tumors labeled " CIMP-high. " CIMP-high can be detected in tumors by screening a panel of genes for the degree of methylation ( 30 ) .
Silencing a gene through promoter hypermethylation is an " epigenetic " rather than a genetic event as it does not involve an alteration in DNA sequence. Clinical associations with CIMPhigh CRCs include older age, female sex, and proximal tumor location ( 31 ) .
Some CIMP-high CRCs resemble Lynch-associated CRCs in that they have loss of DNA mismatch repair capability, evidenced by the presence of MSI. In these tumors, mismatch repair function is lost by promoter hypermethylation of MLH1 (one of several genes required for DNA mismatch repair) rather than by a germline mutation as occurs in Lynch syndrome. Th ese sporadic MSI CRCs also have CIMP, and account for about 15 % of all colon cancers and 4 % of rectal cancers ( 29, 31 ) . BRAF mutations are strongly associated with CIMP-high CRCs where they act as an alternative to the KRAS mutations that occur commonly in chromosomal instability cancers ( 35 -38 ) .
Recognition of these three broad molecular mechanisms underlying CRC (chromosomal instability, MSI, and CIMP) provides molecular tools with which to identify their respective precursor lesions ( Table 3 ) . Many studies have shown common molecular features between benign serrated lesions and CIMP-high CRCs ( 39 -44 ) . Some HPs and most SSA / Ps have BRAF mutations and are CIMP-high, and SSA / Ps with cytological dysplasia frequently have MLH1 hypermethylation and MSI in their dysplastic foci. Although some conventional adenomas are CIMP-high ( 45, 46 ) , it is less common than in SSA / Ps and conventional adenomas do not have BRAF mutations or MSI.
Th e association of molecular markers with the histological subtypes of benign serrated lesions and CIMP-high tumors has led to the proposal of an HP → SSA / P → SSA / P with cytological dysplasia → cancer sequence ( Figure 4 ). Th is sequence occurs most commonly in the proximal colon, though recent evidence indicates a progressive increase in CIMP-high, MSI-high, and BRAF mutations in each colon segment from rectum through ascending colon, suggesting that risk for CIMP-high tumors increases proximally in a continuous rather than dichotomous (colon divided at the splenic fl exure) fashion ( 47 ) .
TSAs are much less common than SSA / Ps, so there are fewer data on their molecular profi le ( 16, 48 ) . TSAs appear to be more molecularly diverse than SSA / Ps in that they may have either KRAS or BRAF mutations or neither, and either low or high levels of CIMP. TSAs typically do not show hypermethylation of MLH1 or develop MSI, but they do commonly have hypermethylation of the DNA repair gene MGMT (O6-methylguanine-DNA methyltransferase) ( 49 ) . MGMT promoter methylation has been associated with both CIMP-low and -high CRCs ( 50 ) . As some HPs do share molecular features of TSAs ( KRAS mutations and CIMP) ( Table 3 ) , it has been suggested that the TSA pathway could diverge from the SSA pathway on the basis of KRAS vs. BRAF mutations and / or MLH1 vs. MGMT hypermethylation within subsets of HPs. However, a defi nite precursor of TSA has not been established.
EPIDEMIOLOGY OF SERRATED LESIONS
Knowledge of the epidemiology of serrated lesions is primarily derived from studies of " hyperplastic " polyps before the recognition of the three subtypes described above.
Autopsy studies demonstrate variable prevalence rates of serrated lesions but collectively indicate that 25 -50 % of white adults have one or more serrated lesions ( 51 -58 ) . Colonoscopic studies show similar variable but lower prevalence rates ( 59 -64 ) . Th e overall prevalence of serrated lesions increases only slightly with age during adulthood ( 51 -61 ) in contrast to conventional adenomas, which increase sharply with age ( 51, 54, 58 ) . HPs are more common in men in some ( 51, 52, 54, 57, 58, 61, 65 ) but not all studies ( 59, 66, 67 ) . Overall, serrated lesions are most common in the sigmoid colon and rectum ( 51 -55,66,67 ) No consistent association has emerged between serrated lesions found on colonoscopy and subsequent adenoma risk in asymptomatic individuals ( 81,93 -98 ) . Some studies have shown serrated lesions to be associated with a higher risk of metachronous serrated lesions, just as adenomas are associated with a higher risk of metachronous adenomas ( 93, 99, 100 ) , though patients with serrated lesions and / or adenomas can demonstrate either type of lesion upon follow up.
Association between serrated lesions and cancer
Case reports describe the development of CRC in serrated lesions left in situ ( 101, 102 ) . Th ere are numerous reported cases of carcinoma with residual SSA / P ( 103, 104 ) . In a pathology series of 2416 SSA / Ps, 14 % demonstrated cytological dysplasia and 1 % showed cancer ( 72 ) . Th e mean age was 61 years in patients with SSA / P without cytological dysplasia, 66 years in those with SSA / P with low-grade cytological dysplasia, 72 years in those with high-grade cytological dysplasia, and 76 years in those with SSA / P with cancer. Th ese fi ndings suggested a mean interval of 15 years for progression of SSA / P without cytological dysplasia to cancer ( 72 ) .
One autopsy study noted a stronger association between serrated lesions and CRC than between adenomas and cancer ( 105 ), which was also found in one endoscopic study ( 92 ) .
SSA / P has been associated with synchronous CRCs with MSI ( 106 ). Serrated lesions ≥ 1 cm in size, which were likely SSA / P in most cases, were strongly associated with synchronous cancer, particularly in the proximal colon ( 107 ) . MSI-high cancers were more likely to be accompanied by serrated lesions than microsatellite stable cancers ( 108 ) . Further studies are required to determine whether this association applies to both HP and SSA / P or predominantly to SSA / P. In addition, synchronous CRCs have higher rates of CIMP-high, MSI, and BRAF mutation than occurs in solitary CRCs ( 109 ) , suggesting that multiplicity is associated with the serrated pathway.
SSA / P has also been associated with an increased risk of metachronous cancer. In case series, a diagnosis of SSA / P carries more of serrated lesions and are predominately right sided ( 66 -74 ) . TSAs are much less common than SSA / Ps. In clinical studies, the prevalence of SSA / Ps is generally < 2 % ( 72,73 ).
Risk factors for serrated lesions
Distal serrated lesions are associated with cigarette smoking ( 61 -63,65,75 -77 ) . Alcohol intake ( 59, 61, 75, 78, 79 ) , fi ber intake ( 75, 79 ) , calcium intake ( 60,78,79 ), non-steroidal anti-infl ammatory drug use ( 60, 75, 79 ) , family history of CRC ( 59, 60, 65, 78, 79 ) , and high body mass index ( 54, 55, 59, 75, 79 ) have had inconsistent associations with distal serrated lesions ( 60, 61, 75, 78, 79 ) . Physical activity has been inversely associated with risk ( 79 ), at least in men ( 75 ) , and folate intake has also been inversely associated with the risk of distal serrated lesions ( 78 ) . Th ere are scant epidemiological data regarding right-sided serrated polyps, but cigarette smoking has been associated with proximal ( 77, 80, 81 ) as well as distal ( 82 ) serrated lesions, and with an overall higher risk of SSA / Ps and large SSA / Ps ( 83 ) .
Association between serrated lesions and adenomas
Autopsy studies show a correlation between numbers of adenomas and serrated lesions, although with diff erent anatomic distributions for the two types of lesions ( 51,54 -56,58 ) . One endoscopic series reported no association between the presence of adenomas and serrated lesions ( 84 ) . At most, there is a modest association between distal serrated lesions and proximal adenomas ( 85 ) . Individuals with SSA / P tend to harbor synchronous adenomas ( 67 -70,73 ) , HPs ( 73 ) , and other SSA / Ps ( 69 ) . Both large and / or proximal serrated lesions have been associated with an increased risk of synchronous advanced conventional neoplasia ( 81 ) , and advanced neoplasia has been associated with the presence of large serrated lesions ( 86, 87 ) . Individuals with both SSA / Ps and conventional adenomas are older, harbor more numerous, larger, and more dysplastic SSA / Ps and conventional adenomas compared with individuals with only SSA / Ps or conventional adenomas ( 88 ) . Any association between HPs and adenomas in Lynch syndrome has been inconsistent ( 89 -92 ). risk for subsequent cancer than a diagnosis of HP. In one study, when 55 patients with SSA / P were followed, fi ve (12.5 % ) developed cancer during 7.2 years of follow-up compared with just one among matched controls with HP and tubular adenoma ( 68 ) . Proximal colon cancers with MSI were associated with serrated lesions at previous colonoscopies, and increasing size of these polyps was associated with shorter intervals between polyp and cancer diagnosis ( 42 ) .
DETECTION OF SERRATED LESIONS
Th e most common serrated lesion is a diminutive left -sided, pale, sessile HP ( 110 ) . Some have a translucent quality and may disappear upon air insuffl ation ( 111 ) . Larger serrated lesions (SSA / P) are typically similar in color to the surrounding mucosa. SSA / Ps and HPs in the proximal colon are oft en covered by a tenacious mucus cap ( Figure 5a ). Th e mucus can cause the polyps to appear yellow, green, or rust-colored and appear red on narrow-band imaging ( Figure 5a ). Care should be taken when washing mucus off the polyp, as the underlying lesion can be diffi cult to detect without it ( Figure 6a-h ) . A recent prospective endoscopic assessment of 158 SSA / Ps identifi ed the mucus cap in 64 % of lesions, a rim of debris or bubbles in 52 % , alteration of the contour of a fold in 37 % , and interruption of the underlying mucosal vascular pattern in 32 % ( 112 ). A number of imaging techniques not usually in use in clinical practice in western countries allow reliable diff erentiation of conventional adenomas from serrated lesions in real time during colonoscopy ( 113 ) . Reliable real-time diff erentiation of HPs from SSA / Ps might not be achievable by endoscopic techniques that image the lesion surface as the characteristic histological features of SSA / P are primarily in the crypt base. However, a recent study found that a modifi ed Kudo pit designated Type II-O is specifi c but not sensitive for SSA / P and highly associated with BRAF mutation and CIMP ( 114 ) . If verifi ed, recognition of these structures would require magnifi cation colonoscopy, which is rarely available in western countries.
SSA / Ps and HPs are almost always sessile or fl at. TSAs tend to be bulkier than SSA / Ps and are occasionally pedunculated, but otherwise pedunculated serrated lesions are rare. SSA / Ps are less discrete than adenomas with borders that can be diffi cult to defi ne. Large SSA / P may develop folds and " wrinkle " when snared, a feature that gives them the appearance of redundant mucosa. It is likely that factors that aff ect colonoscopy quality and detection of fl at and depressed colon neoplasms, such as bowel preparation ( 115 -117 ), withdrawal time, thoroughness of examination, polypectomy technique, and perceptual and personality attributes, will apply to SSA / Ps as well ( 118 ) .
Detection rates of serrated lesions vary dramatically between endoscopists, indicating that these lesions are signifi cantly underdiagnosed in clinical practice ( 73, 119 ) . In one study ( 73 ) , the endoscopy and pathology reports from all average risk-screening colonoscopies at an urban academic medical center over a 3-year period were reviewed. Detection of conventional adenomas varied signifi cantly among endoscopists (from 13.5 to 38.4 % ( P < 0.001)). Detection of HPs (from 7.7 to 31 % , P < 0.001) and SSA / Ps (from 0 to 2.2 % , P = 0.02) also varied signifi cantly. Similar trends were observed for the subset of conventional adenomas, HPs, and SSA / Ps that were located in the proximal colon. In another study ( 119 ) that focused on the prevalence and detection rates of serrated polyps of all subtypes located proximal to the splenic fl exure, the proportion of colonoscopies with at least one proximal serrated polyp ranged from 1 to 18 % , and the detection rates per colonoscopy ranged from 0.01 to 0.26. Th ere was a strong correlation between adenoma detection rates and proximal serrated lesion detection rates. Logistic regression showed that the endoscopist was a more powerful predictor than patient age or gender for proximal serrated lesion detection. Th ese two studies suggest that the true prevalence of serrated lesions is likely to be higher than previously reported and show that serrated lesion detection is highly variable and operator-dependent. Miss rates for serrated lesions have not been specifi cally measured in tandem colonoscopy studies ( 120 ) , but the range of detection rates described thus far indicates that substantial numbers of endoscopists miss more than half of the serrated lesions in the proximal colon ( 73, 119 ) . Recent guidelines on the technical performance of colonoscopy have recommended thresholds for adenoma detection by individual endoscopists, but have not made separate recommendations for detection rates of serrated lesions ( 121, 122 ) . However, three studies suggest a strong correlation between detection of adenomas and serrated lesions by individual endoscopists ( 73,119,123 ). 
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Adjunctive imaging methods such as chromoendoscopy, electronic chromoendoscopy (narrow-band imaging, etc.), and autofl uorescence have generally not been investigated for their value in specifi cally improving the detection of serrated lesions. Table 4 summarizes the major endoscopic and clinical features of serrated lesions.
RECOMMENDATIONS REGARDING REMOVAL OF SERRATED LESIONS
We recommend complete removal of all serrated lesions, except for diminutive sigmoid or rectal lesions. Multiple diminutive ( ≤ 5 mm) serrated-appearing lesions in the rectum and / or sigmoid should be randomly sampled for histology, but complete resection of all diminutive rectosigmoid serrated lesions is unnecessary. Almost all serrated lesions can be excised endoscopically, and the principles of resection are similar to those governing removal of adenomas. Th ree issues that can make endoscopic resection of serrated lesions diffi cult are shared with adenomas: size, shape, and location. Large, fl at lesions are challenging to remove regardless of histology. Lesions surrounding the appendiceal orifi ce or in the ileocecal valve orifi ce may not be endoscopically removable. At least one issue making complete polypectomy diffi cult is relatively specifi c to serrated lesions: identifying the border of the lesion. Although the surface structure of serrated lesions is diff erent from normal mucosa, the true edges of serrated lesions can be diffi cult to identify. Complete endoscopic resection is important and the use of a high-defi nition colonoscope, an electronic highlighting technique (e.g., narrow band imaging), surface dye-spraying, and / or submucosal injection of fl uid containing a contrast agent (e.g., methylene blue or indocyanine green) can assist in identifying the lesion perimeter.
Serrated lesions < 1 cm can be resected with or without electrocautery. For all but the tiniest lesions, cold snaring is more effi cient and eff ective than piecemeal resection using cold forceps ( 124 ) . Cold snaring should include a narrow margin of normal mucosa around the perimeter of the lesion. When electrocautery is used, inclusion of a rim of normal mucosa is not strictly necessary, but is probably safe when submucosal fl uid has been injected and likely helps to ensure complete excision.
Large serrated lesions (most likely to be SSA / P) may actually be easier to snare than large adenomas. Th is is because an SSA / P is generally less attached to the underlying submucosa and can be drawn into the snare more easily. Submucosal injection of these lesions sometimes makes resection more, rather than less, diffi cult by preventing the mucosal wrinkling that facilitates snaring. Th ere is no evidence that resection of large serrated lesions is associated with an increased risk of complications despite their fl at profi le and proximal location, and there may be a reduced incidence of postpolypectomy bleeding ( 71 ) . Piecemeal resection and application of argon plasma coagulation to destroy residual tissue that cannot be snared are appropriate techniques, but of course, the endoscopic approach to large serrated lesions will depend on lesion size, shape, and location, as well as patient age and comorbidities, and the experience and judgment of the endoscopist. When piecemeal technique is used for large serrated lesions, another colonoscopy at 3 to 6 months is recommended to check for completeness of excision. In challenging cases, referral to a more experienced therapeutic colonoscopist should be considered.
Surgical resection of colon containing a serrated lesion is rarely necessary ( 71 ), but is appropriate when a serrated lesion cannot be endoscopically excised. Surgical resection may also be indicated when there are numerous large serrated lesions in the proximal colon.
SERRATED POLYPOSIS SYNDROME (SPS)
SPS (formerly hyperplastic polyposis syndrome) is characterized by multiple serrated (typically SSA / Ps and / or HPs) colorectal polyps. Recently updated WHO criteria defi ne the syndrome by any one of the following conditions: (i) at least fi ve serrated polyps proximal to the sigmoid colon with 2 or more of these being > 10 mm; (ii) any number of serrated polyps proximal to the sigmoid colon in an individual who has a fi rst-degree relative with SPS, or (iii) > 20 serrated polyps of any size, distributed throughout the colon ( 125 ) . However, this defi nition is arbitrary and cannot be validated without a genotype, and no defi nitive gene mutation has yet been identifi ed to correlate with the phenotype.
Th ere is substantial phenotypic diversity ( 125 ) and it is possible that several diff erent but related conditions may be part of SPS. SPS has near equal gender distribution ( 126 -128 ) , with median age at diagnosis of 44 -62 years, and range 10 -90 years ( 126 -128 ) . Serrated lesions in SPS are sessile polyps or fl at lesions. Typically, most are < 1 cm in size, and polyps > 1 cm are more oft en located in the proximal colon. Patients oft en have one or more synchronous adenomas ( 126 -128 ) .
SPS demonstrates hallmarks of a genetic disease, including multiple lesions, younger age of onset of lesions, family history of neoplasia, as well as restricted ethnicity in some studies ( 129, 130 ) , but most cases are sporadic. Th e polyposis is an indication of a " methylator milieu " existing in the mucosa ( 131 ) and acquired either by inheritance or by exposure to as yet unknown environmental agents.
Th e exact risk of CRC in SPS is unknown. Case series have reported up to 25 to 50 % rates of synchronous cancer at diagnosis ( 126 -128,132 -138 ) . A retrospective study found a cumulative risk of CRC of 7 % at 5 years in patients under surveillance ( 126 ) . Th ese estimates are subject to ascertainment bias, however, and the risk estimates are likely to be infl ated.
Surgery is generally indicated in SPS when CRC is diagnosed or when the size and / or number of polyps makes endoscopic control not feasible. Surgery for patients with SPS should include resection of any segment with cancer and at least those segments with large polyps. Extended right hemicolectomy and subtotal colectomy are the most common operations. Annual endoscopic surveillance of any residual colon and rectum is appropriate. When long-term endoscopic management is attempted, annual colonoscopy should be performed with intent to clear the proximal colon of all serrated lesions, or all serrated lesions ≥ 5 mm in size if there are numerous diminutive lesions. Th e surveillance interval and / or the management strategy can be altered if subsequent examinations reveal progressive control or loss of control of the polyp burden.
Nearly half of SPS patients have a family history of CRC ( 128, 132 ) , and one study reported an elevated relative risk of CRC in fi rst-degree relatives of patients with SPS of 5.4 ( 139 ) . It is recommended that screening colonoscopy be performed in fi rst-degree relatives aged ≥ 40 years, or beginning at an age 10 years younger than the age at diagnosis of the youngest aff ected relative. Colonoscopy is recommended at 5-year intervals, or more frequently if polyps are found.
POST-POLYPECTOMY SURVEILLANCE OF PATIENTS WITH SERRATED LESIONS
Post-polypectomy surveillance guidelines in the United States and Great Britain make recommendations for patients with adenomas
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based on observational studies that link baseline colonoscopy adenoma fi ndings to the risk of an advanced adenoma at follow up ( 140, 141 ) . Th ere are few such data available for serrated lesions ( 81, 93, 99, 100 ) , but the strong association of serrated lesions with CIMP-high CRCs has led to calls for specifi c post-polypectomy surveillance guidelines for patients with SSA / Ps. Several authors have already made suggestions in this area ( 13,17,142 -144 ) . Recommendations for surveillance are made here, but considering the paucity of post-polypectomy observational studies addressing follow up of serrated lesions, the recommendations refl ect consensus expert opinion. Th e recommendations are based on the principles presented in Figure 7 , and the collective approaches to serrated lesions of the panel members.
Major limitations of colonoscopy as a tool for preventing CRC include variable lesion detection rates ( 145 -149 ) and variability in effi cacy of polypectomy ( 150 ) . When the rate of missed or persistent lesions varies signifi cantly between endoscopists, it is diffi cult to make surveillance guidelines that protect all patients. Although this applies to adenomas as much as to serrated lesions, cancers developing aft er colonoscopy are more likely to be right-sided, MSI-high, and CIMP-high, suggesting that missed serrated lesions may be a major reason for the relative failure of colonoscopy to protect against right-sided colon cancers ( 151, 152 ) . Th us, the fi rst concern of colonoscopists should be eff ective polyp detection and resection. Because there are data describing standards for adenoma detection rate, and because adenoma detection rate correlates with serrated lesion detection in some studies ( 73, 119 ) , colonoscopists should know their adenoma detection rate. If this is substandard ( < 25 % in average risk men > 50 years having screening colonoscopy, and < 15 % for average risk women > 50 years) ( 121 ), technique and or lesion recognition skills should be improved to bring the adenoma detection rate into acceptable range. No recommendation for a detection threshold of serrated lesions is made here, but this issue is being actively studied. Available data indicate that miss rates and variability in detection are greater for serrated lesions than for adenomas ( 73, 119 ) . Figure 7 presents the conceptual framework that underlies the risk stratifi cation scheme presented in Table 5 . Much of this framework and its basis in the literature in discussed elsewhere in this paper. As noted above, the specifi c recommendations for interval follow up in Table 5 refl ect consensus expert opinion rather than a substantial evidence base. As post-polypectomy surveillance studies of serrated lesions become more available, evidence-based guidelines will be developed that will supersede such recommendations.
Accurate characterization of the number, size and location of lesions is dependent on the endoscopist. Accurate characterization of histology is dependent on the pathologist. Th is paper emphasizes the importance of eff ective detection and resection and also provides pathological criteria for the distinction between HP and SSA / P. Endoscopists and pathologists should share this information and work cooperatively to improve care in their institution, but clinicians should consider use of the SSA / P recommendation when proximal serrated lesions > 1 cm in size are interpreted as HPs, as there is likely substantial variation between pathologists in The interval recommendations presented here represent consensus opinion based on low quality or very low quality evidence. They are likely to change as higher quality evidence becomes available, and alternatives may be equally reasonable. e SSA / P with cytological dysplasia is a more advanced lesion than SSA / P. Depending on the size of the lesion, the confi dence in complete endoscopic resection, and other associated lesions, intervals shorter than 3 years may be appropriate. Note 1 : Patients with both signifi cant serrated polyp fi ndings and concurrent adenomas may be at a more advanced stage in the progression toward cancer. Closer follow up may be indicated in some cases based on clinical judgment. Note 2 : In general, these recommendations for surveillance are for the fi rst follow up. For fi ndings with short follow-up recommendations, a longer subsequent follow-up interval may be appropriately applied when a follow-up exam shows improvement in fi ndings, i.e. reductions in the number, size, and / or histological severity of lesions. Note 3 : Because of interobserver variation in the pathological differentiation of HP from SSA / P, proximal colon serrated lesions >10 mm in size that are designated HP may be considered to be SSA / P by clinicians.
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this regard. Endoscopy fi ndings may be critical for interpretation of histological fi ndings and should be available to pathologists. Given the paucity of observational studies aft er endoscopic resection of serrated lesions ( 81, 93, 99, 100 ) , we sought other evidence to guide surveillance recommendations. We identifi ed several rationales for establishing relatively aggressive surveillance recommendations ( Table 5 ) following resection of serrated lesions pending availability of additional observational studies. First, interval cancers (cancers occurring aft er colonoscopy) are more likely to be right-sided, MSI-high, and CIMP-high ( 151, 152 ) . Given that colonoscopy is less eff ective in preventing proximal than distal cancers ( 145, 146, 153, 154 ) , these data suggest that serrated lesions (and failure to detect serrated lesions) are an important contributor to failure of colonoscopy to prevent CRC. Second, initial studies have found that variability in detection of serrated lesions in the proximal colon is greater ( 73, 119 ) than has been reported for adenomas ( 148, 149 ) , supporting a rationale for relatively close intervals to compensate for increased missing of serrated lesions. Th ird, there are insuffi cient data on the eff ectiveness of endoscopic resection of serrated lesions. However, the very fl at shape of many SSA / Ps, combined with the indiscrete borders of these lesions, raises concerns that incomplete resection of serrated lesions may be an important clinical problem. Th ese factors combine to create a tendency toward aggressive recommendations aft er resection of serrated lesions. However, aggressive post-polypectomy surveillance is acknowledged as a poor replacement for endoscopists who are well trained in lesion recognition, examine the colon carefully, and resect pre-cancerous lesions completely.
Recommendations for post-polypectomy surveillance of patients with serrated lesions are subject to modifi cation based on physician judgment. If multiple types of serrated lesions are present, the shortest recommended interval should be considered. Subsequent colonoscopies that identify no lesions or serrated lesions that are fewer in number, smaller, etc., can be followed by expansion of the interval. When synchronous serrated lesions and conventional adenomas are present, opting for the shorter interval that would be appropriate based on either type of lesion is acceptable or further shortening the interval based on number of lesions of both types may be appropriate.
SUMMARY
Serrated lesions should be classifi ed as HP, sessile SSA / P with or without cytological dysplasia, or TSA. SSA / P is located primarily in the proximal colon, and is an important precursor of CRCs. Cancers arising through the serrated pathway are typically CIMPhigh, demonstrate BRAF mutations, and may demonstrate MSI.
SSA / Ps are fl at or sessile with a distinct endoscopic appearance that is oft en quite subtle. Eff ective colonoscopy requires understanding of the typical appearance of serrated lesions, followed by accurate identifi cation of these lesions. All serrated lesions proximal to the sigmoid and rectosigmoid lesions > 5 mm in size should be fully resected.
Recommendations for colonoscopy surveillance intervals must currently be based on features of serrated lesions that are associated with advanced neoplasia, including synchronous and metachronous CRC. Th ese features include proximal colon location of serrated lesions, increasing number and larger size of serrated lesions, and SSA / P or TSA histology.
